Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway.
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway.
复制标题
DOI:
10.1038/nature23007
复制
发表时间:
2017-07-27
期刊:
影响因子:
64.8
通讯作者:
Schreiber SL
中科院分区:
文献类型:
--
作者:
Viswanathan VS;Ryan MJ;Dhruv HD;Gill S;Eichhoff OM;Seashore-Ludlow B;Kaffenberger SD;Eaton JK;Shimada K;Aguirre AJ;Viswanathan SR;Chattopadhyay S;Tamayo P;Yang WS;Rees MG;Chen S;Boskovic ZV;Javaid S;Huang C;Wu X;Tseng YY;Roider EM;Gao D;Cleary JM;Wolpin BM;Mesirov JP;Haber DA;Engelman JA;Boehm JS;Kotz JD;Hon CS;Chen Y;Hahn WC;Levesque MP;Doench JG;Berens ME;Shamji AF;Clemons PA;Stockwell BR;Schreiber SL
Plasticity of the cell state has been proposed to drive resistance to multiple classes of cancer therapies, thereby limiting their effectiveness. A high-mesenchymal cell state observed in human tumours and cancer cell lines has been associated with resistance to multiple treatment modalities across diverse cancer lineages, but the mechanistic underpinning for this state has remained incompletely understood. Here we molecularly characterize this therapy-resistant high-mesenchymal cell state in human cancer cell lines and organoids and show that it depends on a druggable lipid-peroxidase pathway that protects against ferroptosis, a nonapoptotic form of cell death induced by the build-up of toxic lipid peroxides. We show that this cell state is characterized by activity of enzymes that promote the synthesis of polyunsaturated lipids. These lipids are the substrates for lipid peroxidation by lipoxygenase enzymes. This lipid metabolism creates a dependency on pathways converging on the phospholipid glutathione peroxidase (GPX4), a selenocysteine-containing enzyme that dissipates lipid peroxides and thereby prevents the iron-mediated reactions of peroxides that induce ferroptotic cell death. Dependency on GPX4 was found to exist across diverse therapy-resistant states characterized by high expression of ZEB1, including epithelial-mesenchymal transition in epithelial-derived carcinomas, TGFβ-mediated therapy- resistance in melanoma, treatment-induced neuroendocrine transdifferentiation in prostate cancer, and sarcomas, which are fixed in a mesenchymal state owing to their cells of origin. We identify vulnerability to ferroptic cell death induced by inhibition of a lipid peroxidase pathway as a feature of therapy-resistant cancer cells across diverse mesenchymal cell-state contexts.
登录
查看更多内容
影响因子:
64.5
作者:
Dixon SJ;Lemberg KM;Lamprecht MR;Skouta R;Zaitsev EM;Gleason CE;Patel DN;Bauer AJ;Cantley AM;Yang WS;Morrison B 3rd;Stockwell BR
通讯作者:
Stockwell BR
影响因子:
4
作者:
Dixon SJ;Winter GE;Musavi LS;Lee ED;Snijder B;Rebsamen M;Superti-Furga G;Stockwell BR
通讯作者:
Stockwell BR
DOI:
10.1126/science.aad0501
发表时间:
2016-04-08
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Tirosh I;Izar B;Prakadan SM;Wadsworth MH 2nd;Treacy D;Trombetta JJ;Rotem A;Rodman C;Lian C;Murphy G;Fallahi-Sichani M;Dutton-Regester K;Lin JR;Cohen O;Shah P;Lu D;Genshaft AS;Hughes TK;Ziegler CG;Kazer SW;Gaillard A;Kolb KE;Villani AC;Johannessen CM;Andreev AY;Van Allen EM;Bertagnolli M;Sorger PK;Sullivan RJ;Flaherty KT;Frederick DT;Jané-Valbuena J;Yoon CH;Rozenblatt-Rosen O;Shalek AK;Regev A;Garraway LA
通讯作者:
Garraway LA
影响因子:
--
作者:
Dančík V;Carrel H;Bodycombe NE;Seiler KP;Fomina-Yadlin D;Kubicek ST;Hartwell K;Shamji AF;Wagner BK;Clemons PA
通讯作者:
Clemons PA
影响因子:
64.5
作者:
Gao D;Vela I;Sboner A;Iaquinta PJ;Karthaus WR;Gopalan A;Dowling C;Wanjala JN;Undvall EA;Arora VK;Wongvipat J;Kossai M;Ramazanoglu S;Barboza LP;Di W;Cao Z;Zhang QF;Sirota I;Ran L;MacDonald TY;Beltran H;Mosquera JM;Touijer KA;Scardino PT;Laudone VP;Curtis KR;Rathkopf DE;Morris MJ;Danila DC;Slovin SF;Solomon SB;Eastham JA;Chi P;Carver B;Rubin MA;Scher HI;Clevers H;Sawyers CL;Chen Y
通讯作者:
Chen Y